Cite
HARVARD Citation
Issa, J. et al. (n.d.). Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study. Lancet oncology. 16 (9), pp. 1099-1110. [Online].